NCT04556318View on ClinicalTrials.gov

Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)

CompletedOBSERVATIONAL

Enrollment

396

Participants

Timeline

Start Date

September 23, 2020

Primary Completion Date

June 11, 2021

Study Completion Date

June 11, 2021

Conditions

Covid19

Interventions

DEVICE

Ion Mobility Spectrometry (IMS)

Two breathing gas samples will be taken from each study participant using ion mobility spectrometry with an ultrasound-based spirometer. The total sampling time is 1 minute (at least 5-7 breath takes) following an analysis time of 5-12 minutes.

Trial Locations (2)

Unknown

Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin

Technical University of Munich, Klinikum rechts der Isar, Munich

All Listed Sponsors

lead

B. Braun Melsungen AG

INDUSTRY

NCT04556318 - Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19) | Biotech Hunter | Biotech Hunter